phrykt

Strata Critical Medical, Inc. (SRTA): who owns it and who trades it

As of Nov 16, 2026, SRTA insiders reported 10 open-market sales worth $927K and 3 purchases worth $108K in the last 12 months, with 41% of the sale value made under pre-set 10b5-1 plans. The largest seller was Amir Cohen (Chief Accounting Officer), with $410K. 5 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Strata Critical Medical

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Funds and famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns SRTA

139 funds and institutions reported SRTA shares worth $295M at the end of Q2 2026, about 65% of the company. The largest holder is Third Point LLC with 5.8%.

Funds and institutions (13F) 65%Everyone else 35%

10 largest owners, by share of the company

Third Point LLC5.8%
Northern Right Capital Management, L.P.5.7%
BlackRock, Inc.5.6%
First Eagle Investment Management, LLC5.4%
Royce & Associates LP3.6%
Vanguard Capital Management LLC3.3%
AWM Investment Company, Inc.3.3%
ARK Investment Management LLC3.2%
Pillsbury Lake Capital LLC2.5%
Geode Capital Management, LLC2.0%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Third Point LLC5.00M5.78%$26.4MNo change
Northern Right Capital Management, L.P.4.89M5.65%$25.8M+20%
BlackRock, Inc.4.84M5.59%$25.5M+6%
First Eagle Investment Management, LLC4.63M5.35%$24.4M+104%
Royce & Associates LP3.13M3.62%$16.5M+11%
Vanguard Capital Management LLC2.89M3.33%$15.2M+0%
AWM Investment Company, Inc.2.82M3.26%$14.9MNo change
ARK Investment Management LLC2.73M3.16%$14.4M-63%
Pillsbury Lake Capital LLC2.17M2.51%$11.4M-17%
Geode Capital Management, LLC1.76M2.03%$9.3M+3%
Dimensional Fund Advisors LP1.74M2.01%$9.2M+8%
State Street Corp1.52M1.76%$8M+13%
Uniplan Investment Counsel, Inc.1.43M1.65%$7.5M+10%
Bank of New York Mellon Corp1.14M1.32%$6M+6%
Sumitomo Mitsui Trust Group, Inc.1.05M1.22%$5.5M-36%
Amova Asset Management Americas, Inc.989,1001.14%$5.2M-40%
Northern Trust Corp676,5750.78%$3.6M+5%
Creek Drive Management Group LLC586,2000.68%$3.1M-45%
Citigroup Inc526,8590.61%$2.8M+445%
Vanguard Portfolio Management LLC526,1430.61%$2.8M+9%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, SRTA insiders reported $108K of open-market purchases and $927K of sales. 41% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$108K
3 trades, 2 people
Sales, 12 months
$927K
10 trades, 5 people
Sales under a 10b5-1 plan
41%
Share of sale value
Latest trade
Nov 5, 2026
Filed Nov 9, 2026

Purchases and sales by month

$420K$420KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 5, 2026Andrew LauckDirectorPurchase2,000$5.00$10KForm 4
Aug 10, 2026Reginald LoveDirectorSale5,091$5.75$29.3KForm 4
Jun 8, 2026William A. HeyburnCEOSale31,671$5.87$186KForm 4
Jun 8, 2026Amir CohenChief Accounting OfficerSale4,655$5.87$27.3KForm 4
Jun 8, 2026Melissa M. TomkielCEOSale29,730$5.87$175KForm 4
Jun 8, 2026Scott M WunschCEOSale5,550$5.87$32.6KForm 4
May 22, 2026Amir CohenChief Accounting OfficerSale plan40,575$5.91$240KForm 4
May 21, 2026Amir CohenChief Accounting OfficerSale plan10,300$5.79$59.6KForm 4
May 11, 2026Amir CohenChief Accounting OfficerSale plan14,306$5.79$82.8KForm 4
Dec 9, 2025William A. HeyburnCEOPurchase17,000$4.47$76KForm 4
Dec 5, 2025Andrew LauckDirectorPurchase5,000$4.37$21.9KForm 4
Nov 20, 2025Reginald LoveDirectorSale11,000$4.37$48.1KForm 4
Nov 19, 2025Reginald LoveDirectorSale11,000$4.31$47.4KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Amir CohenChief Accounting Officer–$410KJun 8, 2026
William A. HeyburnCo-CEO and CFO, Director$76K$186KJun 8, 2026
Melissa M. TomkielCo-CEO and General Counsel, Director–$175KJun 8, 2026
Reginald LoveDirector–$125KAug 10, 2026
Scott M WunschCEO, Logistics–$32.6KJun 8, 2026
Andrew LauckDirector$31.8K–Nov 5, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

SRTA short interest

Moderate short interest. 5.1% of SRTA shares are sold short: about 1 share in 20. Over the last 12 reports the number of shares short went down 34%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 4.55M SRTA shares were sold short, 5.1% of the shares outstanding, up 0.3% from the report before. At the average daily volume of 913,746 shares, buying them all back would take about 5.0 trading days (days to cover).

Shares short, % of all shares

5.09%May 15Oct 309.69%

Days to cover

5.0May 15Oct 307.9

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20264.55M5.09%+0%913,7465.0
Oct 15, 20264.54M5.13%+5%907,6565.0
Sep 30, 20264.33M4.90%-1%713,3116.1
Sep 15, 20264.36M4.93%-4%844,7505.2
Aug 31, 20264.53M5.12%+8%820,0575.5
Aug 14, 20264.19M4.74%-0%1.29M3.2
Jul 31, 20264.20M4.75%-3%971,9504.3
Jul 15, 20264.33M5.00%+6%963,6714.5
Jun 30, 20264.08M4.71%-48%1.62M2.5
Jun 15, 20267.82M9.04%+57%1.09M7.2
May 29, 20264.99M5.77%-27%1.04M4.8
May 15, 20266.88M7.95%+7%1.16M6.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Strata Critical Medical company events

Strata Critical Medical filed 8 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 3, 2026.

  1. Nov 3, 2026ResultsReleased financial results. Filing
  2. Aug 4, 2026ResultsReleased financial results. Filing
  3. Jun 3, 2026VoteReported shareholder vote results. Filing
  4. May 6, 2026ResultsReleased financial results. Filing
  5. Mar 3, 2026ResultsReleased financial results. Filing
  6. Feb 5, 2026AgreementStrata Critical Medical, Inc., Strata Critical, Inc., a Delaware corporation and wholly owned subsidiary of the Company, Trinity Air Medical, LLC, an Arizona limited liability company and wholly owned subsidiary of Critical, Keystone Perfusion Services, LLC, a Pennsylvania limited liability company… Filing
  7. Dec 3, 2025LeadershipThe board of directors of Strata Critical Medical, Inc. expanded the size of the Board from eight directors to nine directors and appointed William L. Cook, III to serve as a Class I director, effective immediately, with a term expiring at the Company’s 2027 annual meeting of stockholders. Filing
  8. Dec 2, 2025DealAmended an earlier report. The information set forth in the “Explanatory Note” of this Amendment is incorporated by reference into this Item 2.01. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Strata Critical Medical financials

Famous investors that hold SRTA

5 of the 50 well-known investors we track reported holding SRTA in their latest 13F filing. The largest position is Dan Loeb's, worth $25.6M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Dan Loeb · Third PointQ3 20265.00M$25.6M0.6%No change
Jim Simons · Renaissance TechnologiesQ3 2026352,683$1.8M0.0%-28%
Israel Englander · Millennium ManagementQ3 2026294,270$1.5M0.0%New
Ken Griffin · Citadel AdvisorsQ3 2026191,796$980K0.0%New
Ken Fisher · Fisher Asset ManagementQ3 202610,973$56.1K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named SRTA in the last 120 days.

FiledHolderFormStake
Oct 15, 2026Third Point LLC13D5.8%
Oct 15, 2026Third Point LLC13D5.8%

Questions about Strata Critical Medical, Inc. (SRTA) stock

Who owns the most SRTA stock?

The largest reported owner of Strata Critical Medical, Inc. (SRTA) is Third Point LLC, with 5.8% of the company. In total, 139 funds and institutions reported holding SRTA at the end of Q2 2026, together about 65% of the shares. See the largest owners.

Are SRTA insiders buying or selling?

In the last 12 months, SRTA insiders reported 3 open-market purchases worth $108K and 10 sales worth $927K. The latest trade was on Nov 5, 2026. See every trade.

What is the short interest in SRTA?

As of Oct 30, 2026, 4.55M SRTA shares were sold short, 5.1% of the shares outstanding, up 0.3% from the report before. At the average daily volume of 913,746 shares, buying them all back would take about 5.0 trading days (days to cover). See the history.

Which famous investors hold SRTA?

5 of the 50 well-known investors we track reported SRTA in their latest 13F filing, including Dan Loeb, Jim Simons, Israel Englander. The largest position is worth $25.6M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.